Skip to content

Carbon Dioxide Versus Air Insufflation in Oesophago-gastro-duodenoscopy (OGD)

A Double-blinded, Randomized Trial Comparing Carbondioxide(CO2)and Air Insufflation in Oesophago-gastro-duodenoscopy (OGD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00627211
Enrollment
107
Registered
2008-02-29
Start date
2008-02-29
Completion date
2009-02-28
Last updated
2017-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

quality assessment, pain reduction, gastroscopy, carbondioxide insufflation, Patient satisfaction

Brief summary

Comparison on the effect on patient pain and discomfort by using CO2 instead of air for insufflation during gastroscopy.

Detailed description

To achieve a satisfactory examination of the GI tract it needs to be distended during endoscopic procedures. After the examinations many patients complain of abdominal pain and discomfort. This pain has been substantially reduced by substituting room air with CO2 in both colonoscopies and ERCPs. The use of CO2 during colonoscopy has become routine practice at many endoscopy centers. In our study we will test the hypothesis that abdominal pain after gastroscopies also can be reduced by substituting room air with CO2.

Interventions

From the CO2 rack through the endoscopy rack CO2 will be insufflated to visualize the mucosa during oesophagogastroduodenoscopy.

Sponsors

Norwegian Department of Health and Social Affairs
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for OGD at the outpatient clinic of Telemark Hospital

Exclusion criteria

* Age \<18 * Inability to give an informed concent * Unsatisfactory norwegian language skills * Patients not willing to participate * COPD with dyspnoea NYHA 3-4

Design outcomes

Primary

MeasureTime frame
Pain after OGD0-48 hours

Secondary

MeasureTime frame
Pain during OGD24 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026